Certified Registered Nurse Anesthetist Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Diego Cavenaghi

Nurse Anesthetist, Certified Registered Bakersfield, CA Certified Registered Nurse Anesthetist

NPI 1780962175 CMS profile 11053724

1700 Mount Vernon Ave, Bakersfield, CA 93301

Open in the dashboard

General payments

$3,610

104 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Diego Cavenaghi of Bakersfield, CA is reported in the CMS Open Payments database as having received $3,610 across 104 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Anesthetist, Certified Registered profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $446 18
2024 General $472 19
2023 General $1,265 36
2022 General $1,088 27
2021 General $339 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Diego Cavenaghi
  • Nurse Anesthetist, Certified Registered median
  • Middle half of Nurse Anesthetist, Certified Registered
  • National median

In program year 2025, general payments to Diego Cavenaghi were reported at $446. Among 25,681 Nurse Anesthetist, Certified Registered profiles paid that year, the median was $46 and the middle half received between $23 and $106.

Show as a table
Year Diego Cavenaghi Nurse Anesthetist, Certified Registered median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $339 $34 $17–$77 $132
2022 $1,088 $35 $19–$82 $149
2023 $1,265 $38 $20–$90 $160
2024 $472 $42 $22–$96 $164
2025 $446 $46 $23–$106 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Shockwave Medical, Inc $1,396 46 payments
  2. AngioDynamics, Inc. $1,010 13 payments
  3. Abbott Laboratories $268 3 payments
  4. Impulse Dynamics (USA) Inc. $138 3 payments
  5. Philips Electronics North America Corporation $120 7 payments
  6. Medtronic, Inc. $109 2 payments
  7. Biotronik Inc. $93 5 payments
  8. Asahi Intecc USA, Inc. $78 4 payments
  9. Janssen Pharmaceuticals, Inc $76 4 payments
  10. Boston Scientific Corporation $65 3 payments
  11. Other $258 14 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,610 104 payments
Products named General payments · program years 2021–2025
  1. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Lithoplasty $1,166 37 payments
  2. AURYON LASER SYSTEM 100-120 VAC Pad $733 12 payments
  3. Auryon Laser System 100-120 Vac Et $277 1 payment
  4. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Cardiology $230 9 payments
  5. ASSURITY $206 2 payments
  6. OPTIMIZER Cardiovascular Device $138 3 payments
  7. OPTIMIZER Cardiovascular Device $138 3 payments
  8. LINQ II $82 1 payment
  9. Asahi Coronary Wires $78 4 payments
  10. XARELTO $76 4 payments
  11. Other $658 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$442,804

Medicare's payments for the services billed

Medicare patients

384

Average age 76

Services billed

1,716

183 women, 201 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 71%
Arthritis 68%
Ischemic heart disease 59%
Heart failure 43%
Chronic kidney disease 42%
Atrial fibrillation 31%
Depression 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
  • Janssen Pharmaceuticals, Inc $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

104 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record